Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease lymphoma
Phenotype C0021831|bowel disease
Sentences 14
PubMedID- 24574759 Primary effusion lymphoma-like lymphoma in a patient with inflammatory bowel disease.
PubMedID- 21887728 Background: prior studies suggest an increased risk of lymphoma in adults with inflammatory bowel disease (ibd).
PubMedID- 22766526 Background and aims: prior studies suggest a small but significantly increased risk of lymphoma in adults with inflammatory bowel disease (ibd), especially in patients treated with thiopurines.
PubMedID- 25253369 There were a few reports of malt lymphoma occurring in patients with inflammatory bowel diseases, including ulcerative colitis (uc) and crohn's disease.
PubMedID- 25984171 Revealed a 4-fold increased risk of lymphoma in patients with inflammatory bowel disease, treated with azathioprine [9].
PubMedID- 23535248 Risk factors for lymphoma in patients with inflammatory bowel disease: a case-control study.
PubMedID- 22347833 Risk of lymphoma in patients with inflammatory bowel disease.
PubMedID- 22626508 However, aza is associated with an increased risk of lymphoma in patients with inflammatory bowel disease.
PubMedID- 24879926 Risk of lymphoma in patients with inflammatory bowel disease treated with azathioprine and 6-mercaptopurine: a meta-analysis.
PubMedID- 21830262 Risk of malignant lymphoma in patients with inflammatory bowel diseases: a dutch nationwide study.
PubMedID- 21674712 Primary intestinal lymphoma in patients with inflammatory bowel disease: a descriptive series from the prebiologic therapy era.
PubMedID- 20888436 A systematic review of factors that contribute to hepatosplenic t-cell lymphoma in patients with inflammatory bowel disease.
PubMedID- 22545014 Patients with concurrent medical or arthritic conditions that could interfere with evaluation of the index knee joint, including fibromyalgia, reiter's syndrome, rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, lymphoma, arthritis associated with inflammatory bowel disease, sarcoidosis, amyloidosis, clinical signs and symptoms of active knee infection, crystal disease, cancer, more significant pain from the back or the hip than the knee, patients with hiv or hcv, and patients with drug or alcohol dependence history or sensitivity to polymerized-type i collagen were also excluded.
PubMedID- 23390943 Loss of response to biologics versus increased risk of lymphoma in children with inflammatory bowel disease: the clinician's conundrum.

Page: 1